Further investigation of AHR regulation of ACE2 and the downstream effects of the ACE2 cleavage product, Ang-(1–7), on Mas and AT2R may identify novel therapeutic targets in hypertension and fibrosis. The gene discussed is MAS1; the disease is hypertensive disorder.